Work

Faculty Opinions recommendation of EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Year: 2004

Type: peer-review

Source: Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature

DOI: 10.3410/f.1016183.212479

Author: William Kaelin

Institution: Dana-Farber Cancer Institute

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4235983319

Cites:

Cited by:

Related to: 6